Skip to content
General News, Medical Health Aged Care

New research shows alcohol industry drags feet on mandated pregnancy warning

Australian and New Zealand Journal of Public Health / Public Health Association of Australia 4 mins read

Wednesday 5 February 2025

 

Experts are concerned that the alcohol industry may be deliberately delaying the inclusion of Government-mandated pregnancy warnings across its products, after new research showed only 63 per cent of alcoholic beverages displayed the label - despite being given a generous three-year grace period to comply.1

 

The study by The George Institute for Global Health, published today in the Australian and New Zealand Journal of Public Health, analysed around 6,000 alcohol products sold in four large stores in Sydney from June to November 2023, to uncover the worrying finding.

 

The warning labels are intended to ensure consumers are informed that drinking while pregnant increases the risk of potential life-long health issues in unborn children.Businesses were given three years from 31 July 2020 to 31 July 2023 to implement these requirements.

 

Lead author of the new paper, Professor Simone Pettigrew, Head of Health Promotion at The George Institute for Global Health and Professor at the Faculty of Medicine, UNSW Sydney, said the research demonstrates the need for improved alcohol health warning regulation and more thorough Government monitoring to protect babies’ health.

 

“The industry fought hard against pregnancy warning labels when they were mandated by Government in 2020, after 20 years of lobbying to bring Australia in line with the evidence and WHO recommendations,” she said. “Yet, even with three years to display standardised pregnancy warnings on all new packaging, more than a third of products we analysed did not do so.

 

“Our analysis purposely straddled the end of the transition period, and the results suggest that alcohol companies may have deliberately used the phase-in period as a loophole to delay introducing mandated pregnancy warnings for fear of losing sales.

 

“Most alarmingly, only half of spirits, which have the highest levels of alcohol by volume, showed the pregnancy warning,” she said.

 

Other studies have demonstrated that some Australian women remain confused about whether they can drink alcohol while pregnant - around one-third of women say they have.Giving women warning information has been shown to motivate them to avoid drinking while pregnant.4,5

 

Prof Pettigrew said the analysis found that 25 per cent of alcohol products carried their own versions of pregnancy warnings instead, a concern because research consistently shows that industry-designed warnings are less effective than warnings developed using evidence-based approaches.6

 

Evidence shows drinking alcohol during pregnancy can cause low birthweight, premature birth, and foetal alcohol spectrum disorder (FASD) in unborn babies, leading to health issues throughout life that can include physical, cognitive, developmental, and behavioural problems.2

 

FASD is an emerging public health issue in Australia, with data suggesting it impacts between 1 and 5 per cent of children in high income countries. More local data is needed to respond adequately, especially for the most vulnerable groups. 

 

Adjunct Professor Terry Slevin, CEO, Public Health Association of Australia, said the study confirms government must take much stronger action on alcohol warnings to help Australians make informed choices about their drinking and reduce the harms it causes in our community.

 

“When it comes to alcohol and health, it’s time to stop leaving the fox in charge of the henhouse. This latest research shows that the alcohol industry has no interest in protecting the health of Australians and will avoid and delay introducing mandated health warnings until the last minute and beyond.

 

“As we approach the Federal Election, public health experts are asking the next Australian Government to take meaningful action on obesity, including the marketing of unhealthy food and beverages, and mandating Health Star Ratings on packaged foods. We also want to see kilojoule labelling on alcohol so people can see how much alcoholic beverages contribute to the energy they consume – and so the potential contribution to their waistline,” he said.

 

“The message from this research is that we can’t rely on the food and beverage industry to self-regulate the labels of their unhealthy products and when new regulation is introduced, we shouldn’t allow for generous phase in periods which they might exploit.”

 

-ends-

 

Media enquiries

Rachel Harris, The George Institute for Global Health 
P: +61 410 411 983 / E: 
[email protected]

 

Hollie Harwood, Public Health Association of Australia

P: +61 400 762 010 / E: [email protected]

 

Images of the mandatory pregnancy warning labels are available upon request.  

 

“The prevalence of mandated and voluntary health information on alcohol products in Australia” has been published online in the Australian and New Zealand Journal of Public Health here.

 

Please credit the journal.

 

The Journal is the official publication of the Public Health Association of Australia. All articles are open access and available here: https://www.sciencedirect.com/journal/australian-and-new-zealand-journal-of-public-health

 

The George Institute for Global Health

The George Institute for Global Health is an independent medical research institute aiming to improve the health of millions of people worldwide by generating effective, evidence-based and affordable solutions to the world’s biggest health challenges. Established in Sydney, with major centres in China, India and the UK, it has projects in more than 45 countries and affiliations with world-class universities. In 2018, The George Institute was ranked the number one independent research institute in Australia by Times Higher Education.

 

X @georgeinstitute         Web www.georgeinstitute.org        LinkedIn The George Institute for Global Health

 

About the Public Health Association of Australia
We’re Australia's peak body for public health and advocate for the health and wellbeing of everyone. We strive to help prevent – rather than cure – illness and disease. We represent around 2,000 individual members from more than 40 professional groups interested in the promotion of public health. We have branches in every State and Territory. Learn more at phaa.net.au

 

References:

1 Pettigrew, S et al (2025) The prevalence of mandated and voluntary health information on alcohol products in Australia, Australian and New Zealand Journal of Public Health, In Press 

2. Australia's mothers and babies, Alcohol consumption during pregnancy - Australian Institute of Health and Welfare. Accessed December 2024

3. Australian Institute of Health and Welfare. National Drug Household Survey 2019. Canberra: AIHW; 2020. (Drug Statistics series no. 32. PHE 270.)

4. Pettigrew, S., Booth, L., McCausland, T., Kennington, K., Miller, M., Bowden, J., & Stafford, J. (2023). Evaluation outcomes of an alcohol and pregnancy campaign targeting multiple audiences. Drug and Alcohol Review, 42(1), 36-45 

5. Pettigrew, S., Booth, L., McCausland, T., Kennington, K., & Keric, D. (2023). Evaluation outcomes of a Western Australian campaign designed to reduce alcohol use in pregnancy. Australian and New Zealand Journal of Public Health, 47(6), 100102

6. Brennan E, Schoenaker DA, Durkin SJ, Dunstone K, Dixon HG, Slater MD, Pettigrew S, Wakefield MA. Comparing responses to public health and industry-funded alcohol harm reduction advertisements: an experimental study. BMJ open. 2020 Sep 1;10(9):e035569

More from this category

  • Medical Health Aged Care
  • 10/02/2026
  • 23:41
Helus Pharma

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLCProven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programsAppointed as Helus Pharma advances its pipeline toward key clinical milestones, including expected Phase 2 data for HLP004 this quarter and Phase 3 topline data for HLP003 later this yearThis news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to it short form…

  • General News
  • 10/02/2026
  • 23:11
NetBox Labs

NetBox Labs Announces General Availability of NetBox Copilot, Delivering Enterprise-Ready AI Grounded in Accurate Infrastructure Data

NetBox Copilot accelerates operations and automation, while providing self-service to non-IT teamsNEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Today, NetBox Labs, the central nervous system for networks and infrastructure, announced the general availability of NetBox Copilot, an interactive AI agent embedded directly into the NetBox platform.As AI agents rapidly move from experimentation into production operations, IT teams are finding that most agents lack the accurate operational context required to be trusted in production environments. NetBox delivers a critical foundation for automation. It is a comprehensive semantic map for infrastructure that enables NetBox Copilot with complete infrastructural context. NetBox Copilot is…

  • Medical Health Aged Care
  • 10/02/2026
  • 19:26
Takeda Pharmaceutical Company Limited

U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1

This FDA Acceptance is a Milestone for People Living with Narcolepsy Type 1 Who Need New and Different Treatment Options Oveporexton is an Orexin…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.